Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Visiting Professor







c/o Prof Kim FoxGuy Scadding BuildingRoyal Brompton Campus





Patrick W. Serruys has been a senior interventional cardiologist since 1977, Chief of Interventional Research since 1988, the Chief of Interventional Cardiology at the Thorax center from 1997-2012, Prof. of Medicine till April 1st 2014 at Erasmus MC.

Dr. Serruys was the first chair of interventional cardiology created by the Royal Netherlands Academy of Arts and Sciences ( Currently he is professor of Cardiology in the Cardiovascular Science Division of the National Heart and Lung Institute (NHLI) of Imperial College in London (UK).

Between 1976 and 1982, before the era of interventional cardiology, Professor Serruys established the methodology of quantitative coronary angiography with the bioengineering group within EMC. In 1980 the balloon angioplasty was introduced at the Thorax Centre, and Professor Serruys was scientifically challenged and tried to elucidate the phenomenon of restenosis post angioplasty in a multidisciplinary approach. In those days, Professor Serruys developed his world-wide networks with various experts to unravel the problem of restenosis. After multiple unsuccessful pharmacological trials to control restenosis phenomenon, his scientific focus was shifted to mechanical device engineering such as stenting. In 1986 he introduced this technique in patients in the Netherlands.

Using the latest scientific and experimental knowledge in the field of molecular biology of neointimal inhibition, Professor Serruys and Eduardo Sousa in Brazil introduced the use of drug-eluting stent for the first time in the world, this was in 1999. Professor Serruys revolutionized the field of interventional cardiology by drastically abating the restenosis rate post intervention; however, the implantation of permanent metallic prosthesis was viewed as a major drawback in the treatment of coronary artery stenosis. Therefore in 2006 Professor Serruys introduced worldwide the use of fully biodegradable drug-eluting scaffolds that eliminated the presence of a permanent metallic foreign body in the coronary circulation. In the next decade, Professor Serruys will dedicate his scientific and clinical career to re- revolutionize the field of interventional cardiology by altering the atherosclerotic process and the process through local percutaneous treatment.



Ozaki Y, Katagiri Y, Onuma Y, et al., 2018, CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018, Cardiovascular Intervention and Therapeutics, Vol:33, ISSN:1868-4300, Pages:178-203

Chiastra C, Iannaccone F, Grundeken MJ, et al., 2016, Coronary fractional flow reserve measurements of a stenosed side branch: a computational study investigating the influence of the bifurcation angle, Biomedical Engineering Online, Vol:15, ISSN:1475-925X

Oemrawsingh RM, Cheng JM, Akkerhuis KM, et al., 2016, High-sensitivity C-reactive protein predicts 10-year cardiovascular outcome after percutaneous coronary intervention, Eurointervention, Vol:12, ISSN:1969-6213, Pages:345-351

Sotomi Y, Tateishi H, Suwannasom P, et al., 2016, Quantitative assessment of the stent/scaffold strut embedment analysis by optical coherence tomography, International Journal of Cardiovascular Imaging, Vol:32, ISSN:1875-8312, Pages:871-883

Tenekecioglu E, Farooq V, Bourantas CV, et al., 2016, Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention, Bmc Cardiovascular Disorders, Vol:16, ISSN:1471-2261

More Publications